Search
for
Sort by
Research 721–750 of 904
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Linagliptin-Associated Alopecia and Bullous Pemphigoid
- Intralesional triamcinolone acetonide versus platelet rich plasma: a comparative study in the treatment of alopecia areata of scalp
- A novel actor in skin biology: the mineralocorticoid receptor
- Review of Superficial Cryotherapy for the Treatment of Alopecia Areata
- Eyebrow and Eyelash Alopecia: A Clinical Review
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- Outcome domains in lichen sclerosus
- Topical and transdermal lipid-polymer hybrid nanoparticles (LPN): an integration in advancing dermatological treatments
- Allergic contact dermatitis of the scalp: a review of an underdiagnosed entity
- Dermal TRPV1 innervations engage a macrophage- and fibroblast-containing pathway to activate hair growth in mice
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Nutritional Disorders of the Hair and Their Management
- Comprehensive Overview and Treatment Update on Hair Loss
- Alopecia areata
- Advances in Nanocarrier Systems for Dermatologic Transdermal Drug Delivery: A Chemical and Molecular Review
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Methodologies to Evaluate the Hair Follicle-Targeted Drug Delivery Provided by Nanoparticles
- Trace element zinc and skin disorders
- Zinc and Zinc Transporters in Dermatology
- Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Hesperidin from Orange Peel as a Promising Skincare Bioactive: An Overview
- Alopecia Areata after COVID-19 Vaccines
- Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Applications of Antioxidant Nanoparticles in Immune-Mediated Inflammatory Diseases
- Off-label dermatologic uses of IL-23 inhibitors
- Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy